Durvalumab and Tremelimumab Versus Doxorubicin in Previously Untreated Patients with Advanced or Metastatic Soft Tissue Sarcoma: Patient-reported Outcomes (pros) of the Randomized Phase II MEDISARC Study (AIO-STS-0415).

Viktor Gruwald, Barbara Hermes,Armin Tuchscherer, Sebastian Bauer,Rainer Hamacher,Daniel Pink, Lars H. Lindner, Stefan Groeschel,Peter Reichardt,Stephan Richter, Christoph Oing,Marinela Augustin,Martina Margrit Crysandt, Martin Kortuem, Bernd Kasper, Marc Fischer,Philipp Ivanyi

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views2

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined